4.8 Review

Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance

Journal

ONCOGENE
Volume 36, Issue 22, Pages 3067-3079

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2016.462

Keywords

-

Funding

  1. Ministere de l'Enseignement Superieur et de la Recherche
  2. Fondation de France [2011-00025574, 2014 00047502]
  3. Fondation ARC [DOC20130606463, PDF2014601431]
  4. La Ligue National contre le Cancer [RS14/75-112]
  5. GEFLUC
  6. Spanish Association for the Study of the Liver (AEEH)

Ask authors/readers for more resources

The transmission of cellular information requires fine and subtle regulation of proteins that need to interact in a coordinated and specific way to form efficient signaling networks. The spatial and temporal coordination relies on scaffold proteins. Thanks to protein interaction domains such as PDZ domains, scaffold proteins organize multiprotein complexes enabling the proper transmission of cellular information through intracellular networks. NHERF1/EBP50 is a PDZ-scaffold protein that was initially identified as an organizer and regulator of transporters and channels at the apical side of epithelia through actin-binding ezrinmoesin-radixin proteins. Since, NHERF1/EBP50 has emerged as a major regulator of cancer signaling network by assembling cancerrelated proteins. The PDZ-scaffold EBP50 carries either anti-tumor or pro-tumor functions, two antinomic functions dictated by EBP50 expression or subcellular localization. The dual function of NHERF1/EBP50 encompasses the regulation of several major signaling pathways engaged in cancer, including the receptor tyrosine kinases PDGFR and EGFR, PI3K/PTEN/AKT and Wnt-beta-catenin pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available